Join the Sites NOW community as our panel of leading clinical research experts discuss global trends impacting oncology research sites in 2022. Learn more about the evolution of technology, patient experience, and pandemic related impact on cancer research. Tune-in and gain a preview of some of the hottest topics ahead of the 2022 Global Oncology Site Solutions Summit in Austin, TX Jan 28-29, 2022.
Peter Fredette has almost 20 years of experience in the drug development industry, including pre-clinical toxicology and all phases of clinical research. He is most experienced in oncology but has worked across many therapeutic areas. Peter’s current responsibilities include supporting CRO-Site alliances and thought leader engagement; site strategies for global and domestic oncology trials; and creating and implementing strategies to improve quality and accessibility of clinical trials for cancer patients around the world. Prior to this, Peter has held a variety of roles at IQVIA over the last 17 years, including trial monitoring, project management, and site & investigator relations.
Alexa Florea is an accomplished collaborative visionary with a track record of cultivating high performing teams serving patients, caregivers, and investigative partners. She has 20 years of Pharma-Biotech experience across diagnostic laboratories, clinical data management & analysis, and clinical operations.
Rosemary is Director of Research at QCCA, a network of 14 community based oncology practices, conducting research in malignant hematology and oncology. She is a registered nurse with 24 years experience in clinical research. She has worked in a variety of positions within Pharma, CROs, and at a large clinical site. Prior to joining QCCA, Rosemary worked in site relationship roles at Parexel and Syneos Health.
